Assignee
IBIO INC
US·16 granted patents·15 pending applications·28 citations·filing 2005–2024
Top patents by PatentIndex Score
31 records- 0190US12215163B2CD25 antibodiesIBIO INC·Filed 2021·Granted Feb 4, 2025·3 cites·24 claims
- 0287US8951791B2System for expression of genes in plantsIBIO INC·Filed 2013·Granted Feb 10, 2015·4 cites·16 claims
- 0386US11545238B2Machine learning method for protein modelling to design engineered peptidesIBIO INC·Filed 2020·Granted Jan 3, 2023·3 cites·18 claims
- 0485US7692063B2Production of foreign nucleic acids and polypeptides in sprout systemsIBIO INC·Filed 2006·Granted Apr 6, 2010·9 cites·10 claims
- 0582US12129302B2Anti-CD-25 antibodyIBIO INC·Filed 2022·Granted Oct 29, 2024·2 cites·22 claims
- 0680US9115201B2Humanized neuraminidase antibody and methods of use thereofIBIO INC·Filed 2014·Granted Aug 25, 2015·4 cites·4 claims
- 0775US7691429B2Nutritional supplements containing methylselenocysteineIBIO INC·Filed 2005·Granted Apr 6, 2010·2 cites·6 claims
- 0874US2025122301A1Cd25 antibodiesIBIO INC·Filed 2024·Application pending·0 cites
- 0971US10844392B2Materials and methods for producing endostatin fusion polypeptides in plant cellsIBIO INC·Filed 2016·Granted Nov 24, 2020·1 cites·19 claims
- 1066US11912755B2Endostatin fragments and variants for use in treating fibrosisIBIO INC·Filed 2020·Granted Feb 27, 2024·0 cites·4 claims
- 1165US9765349B2System for expression of genes in plantsIBIO INC·Filed 2017·Granted Sep 19, 2017·0 cites·20 claims
- 1263US2023095685A1Machine learning method for protein modelling to design engineered peptidesIBIO INC·Filed 2022·Application pending·0 cites
- 1363US2025034267A1Anti-cd-25 antibodyIBIO INC·Filed 2024·Application pending·0 cites
- 1461US9551001B2System for expression of genes in plantsIBIO INC·Filed 2015·Granted Jan 24, 2017·0 cites·18 claims
- 1560US9012199B2Recombinant carrier molecule for expression, delivery and purification of target polypeptidesIBIO INC·Filed 2013·Granted Apr 21, 2015·0 cites·20 claims
- 1656US12473368B2CD25 antibodiesIBIO INC·Filed 2021·Granted Nov 18, 2025·0 cites·12 claims
- 1756US9809644B2Influenza hemagglutinin antibodies, compositions and related methodsIBIO INC·Filed 2014·Granted Nov 7, 2017·0 cites·13 claims
- 1856US2024327515A1Anti-cd3 antibodiesIBIO INC·Filed 2024·Application pending·0 cites
- 1956US2024092909A1Pd-1 agonist antibodiesIBIO INC·Filed 2023·Application pending·0 cites
- 2056US2025019457A1Trop2 antibodiesIBIO INC·Filed 2024·Application pending·0 cites
- 2156US2025066478A1High-efficiency, conditionally-activated antibody discovery and masked antibodiesIBIO INC·Filed 2024·Application pending·0 cites
- 2256US2024262929A1Anti-muc16 antibodiesIBIO INC·Filed 2024·Application pending·0 cites
- 2356US2024117056A1Epidermal growth factor receptor variant iii antibodiesIBIO INC·Filed 2023·Application pending·0 cites
- 2455US8945580B2Yersinia pestis antigens, vaccine compositions, and related methodsIBIO INC·Filed 2013·Granted Feb 3, 2015·0 cites·29 claims
- 2555US2024228637A9Chemokine receptor 8 (ccr8) antibodiesIBIO INC·Filed 2023·Application pending·0 cites
- 2649US2019048358A1Expression of Foreign Sequences in Plants Using Trans-Activation SystemIBIO INC·Filed 2018·Application pending·0 cites
- 2747US12441803B2Engineered CD25 polypeptides and uses thereofIBIO INC·Filed 2021·Granted Oct 14, 2025·0 cites·10 claims
- 2846US2022372080A1Sars-cov-2 subunit and variant vaccinesIBIO INC·Filed 2022·Application pending·0 cites
- 2944US2011070609A1Production of Foreign Nucleic Acids and Polypeptides in Sprout SystemsIBIO INC·Filed 2010·Application pending·0 cites
- 3042US2024096443A1Generalized Scaffolds for Polypeptide Display and Uses ThereofIBIO INC·Filed 2021·Application pending·0 cites
- 3141US2021283243A1Lichenase-covid-19 based vaccineIBIO INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →